LIBERTY CORNER, N.J., Nov. 20 /PRNewswire/ -- Reliant Pharmaceuticals, Inc. today announced that Joseph Zakrzewski, the company’s Chief Operating Officer, will present at the Lazard Capital Markets Third Annual Life Sciences Conference on Tuesday, November 28 at 4:00 PM Eastern. The conference is being held at the New York Palace.
Mr. Zakrzewski will provide an overview of Reliant and an update on the company’s product portfolio.
About Reliant Pharmaceuticals, Inc.
Reliant Pharmaceuticals is a pharmaceutical company with integrated sales, marketing and development expertise that markets a portfolio of branded cardiovascular pharmaceutical products. Reliant focuses on marketing promotionally sensitive pharmaceutical products to the high prescribing primary care, cardiovascular and specialist physician markets in the United States. Reliant also acquires rights to and develops product candidates in mid- to late-stage clinical development. Reliant’s sales force infrastructure is comprised of approximately 800 sales professionals nationwide.
Reliant Pharmaceuticals, Inc.
CONTACT: Marylou Rowe, Investor Relations Manager of ReliantPharmaceuticals, Inc., +1-908-860-4646, investorrelations@reliantrx.com
Web site: http://www.reliantrx.com/
